Vimarsana
Biggest News Aggregation in the World

Page 2 - Briggs Morrison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Briggs Morrison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Briggs Morrison Today - Breaking & Trending Today

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Rating of "Buy" from Brokerages - Vimarsana News

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Rating of "Buy" from Brokerages

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine analysts that are presently covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have issued a report on the […]

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $36.00 Consensus PT from Analysts - Vimarsana News

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $36.00 Consensus PT from Analysts

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have been assigned an average recommendation of “Buy” from the nine brokerages that are covering the stock, Marketbeat.com reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have issued ratings on the […]

Source: wkrb13.com
Axiom Investors LLC DE Purchases Shares of 28,195 Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Vimarsana News

Axiom Investors LLC DE Purchases Shares of 28,195 Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

Axiom Investors LLC DE acquired a new position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 28,195 shares of the company’s stock, valued at approximately $595,000. A number of other hedge funds […]

Source: wkrb13.com
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Recommendation of "Buy" by Brokerages - Vimarsana News

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Recommendation of "Buy" by Brokerages

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have earned a consensus recommendation of “Buy” from the nine research firms that are currently covering the company, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have issued a report on […]

Source: wkrb13.com
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of "Buy" from Brokerages - Vimarsana News

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of "Buy" from Brokerages

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have earned an average rating of “Buy” from the nine analysts that are currently covering the company, MarketBeat reports. Nine analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have covered the stock in the last year […]